Abstract
This study was undertaken to validate the potential of 31P magnetic resonance spectroscopy (MRS) as a noninvasive alternative for transvenous endomyocardial biopsy in detecting cardiac allograft rejection. Donor hearts from either Lewis rats (L) or Brown-Norway rats (BN) were transplanted into the neck of L rats resulting in a non-rejecting group L-L and a rejecting group L-BN. L-L and L-BN rats were serially studied by means of 31P MRS from postoperatine day 1–8. In addition, rejection was confirmed by histology. A similar, marked decrease in phosphocreative/β-adenosinetriphosphate (PCr/ATP) ratio from day 1–3 was observed in both L-L and L-BN hearts. This ratio levelled off on postoperative day 3 and remained depressed on subsequent postoperative days in both groups, although histology showed an increase in the severity of rejection in L-BN. However, the PCr signal/noise ratio in L-BN started to decrease after day 4, coinciding with the histologic evidence of severe rejection (score IV), whereas in L-L hearts (score 0) this ratio remained unaltered until day 8. Since high-energy phosphate metabolism is affected by the unloaded status of the heterotopically transplanted heart, irrespective of rejection, the PCr/ATP ratio appears not to be a specific marker for the detection of acute rejection in this model. In contrast, the PCr S/N ratio appears to be a specific and sensitive marker of acute rejection, but only in a late, severe stage.
Similar content being viewed by others
References
Billingham ME: Diagnosis of cardiac rejection by endomyocardial biopsy. J Heart Transplant 1: 25–30, 1981
Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group. J Heart Transplant 9: 587–593, 1990
Hosenpud JD: Noninvasive diagnosis of cardiac allograft rejection: Another ofmany searches for the grail. Circulation 82: 368–371, 1992
Haug CE, Shapiro JI, Chan L, Weil R: P-31 nuclear magnetic resonance spectroscopic evaluation of heterotopic cardiac allograft rejection in the rat. Transplantation 44: 175–178, 1987
Haug CE, Shapiro JI, Cosby RL, Chan L, Weil R: 31P nuclear magnetic resonance spectroscopy of heart, heart-lung, and kidney allograft rejection in the rat. Transplant Proc 20: 848–855, 1988
Canby RC, Evanochko WT, Barrett LV, Kirklin JK, McGiffin DC, Sakai TT, Brown ME, Foster RE, Reeves RC, Pohost GM: Monitoring the bioenergetics of cardiac allograft rejection using in vivo P-31 nuclear magnetic resonance spectroscopy. J Am Coll Cardiol 9: 1067–1074, 1987
Fraser CD, Chacko VP, Jacobus WE, Soulen RL, Hutchins GM, Reitz BA, Baumgartner WA: Metabolic changes preceding functional and morphologic indices of rejection in heterotopic cardiac allografts. Transplantation 46: 346–351, 1988
Fraser CD, Chacko VP, Jacobus WE, Hutchins GM, Glickson J, Reitz BA, Baumgartner WA: Evidence from 31P nuclear magnetic resonance studies of cardiac allografts that early rejection is characterized by reversible biochemical changes. Transplantation 48: 1068–1070, 1989
Fraser CD, Chacko VP, Jacobus WE, Mueller P, Soulen RL, Hutchins GM, Reitz BA, Baumgartner WA: Early phosphorus 31P nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts. J Heart Transplant 9: 197–204, 1990
Walpoth BH, Tschopp A, Lazeyras F, Galdikas J, Tschudi J, Altermatt H, Schaffner T, Aue WP, Althaus U: Magnetic resonance spectroscopy for assessing myocardial rejection in the transplanted rat heart. J Heart Lung Transplant 12: 271–282, 1993
Bottomley PA, Weiss RG, Hardy CJ, Baumgartner WA: Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. Radiology 181: 67–75, 1991
Miller JE, Tschoepe RL, Ziegler MM: A new model of heterotopic rat heart transplantation with application for in vivo 31P nuclear magnetic resonance spectroscopy. Transplantation 39: 555–558, 1985
Rozenman Y, Kantor HL: Heterotopic transplanted rat heart: a model for in vivo determination of phosphorus metabolites during ischemia and reperfusion. Magn Reson Med 13: 450–457, 1990
Mazzeo AR, Levy GC: An evaluation of new processing protocols for in vivo NMR spectroscopy. Magn Reson Med 17: 483–495, 1991
Brindle KM, Rajagopalan B, Williams DS, Detre JA, Simplaceanu E, Ho C, Radda GK: 31P NMR measurements of myocardial pH in vivo. Biochem Biophys Res Commun 151: 70–77, 1988
Brindle KM, Rajagopalan B, Bolas NM, Radda GK: Editing of 31P NMR spectra of heart in vivo. J Magn Reson 74: 356–365, 1987
Rajagopalan B, Bristow JD, Radda GK: Measurement of transmural distribution of phosphorus metabolites in the pig heart by 31P magnetic resonance spectroscopy. Cardiovasc Res 23: 1015–1026, 1989
Katz LA, Swain JA, Portman MA, Balaban RS: Intracellular pH and inorganic phosphate content of heart in vivo: a 31P-NMR study. Am J Physiol 255: H189-H196, 1988
Suzuki S, Kanashiro M, Amemiya H: Effect of a new immunosuppressant, 15-deoxyspergualin, on heterotopic rat heart transplantation, in comparison with cyclosporine. Transplantation 44: 483–487, 1987
Portman MA, Heineman FW, Balaban RS: Developmental changes in the relation between phosphate metabolites and oxygen consumption in the sheep heart in vivo. J Clin Invest 83: 456–464, 1989
Gober JR, Schaefer S, Camacho SA, DeGroot M, Obregon R, Botvinick EH, Weiner M, Massie BM: Epicardial and endocardial localized 31P magnetic resonance spectroscopy: Evidence for metabolic heterogeneity during regional ischemia. Magn Reson Med 13: 204–215, 1990
Gober JR, Schwartz GG, Schaefer S, Massie BM, Matson GB, Weiner MW, Karczmar GS: 31P MRS of myocardial inorganic phosphate using radiofrequency gradient echoes. Magn Reson Med 20: 171–183, 1991
Reemtsma K, Delgado JP, Creech O: Transplantation of the homologous canine heart: serial studies of myocardial blood flow, oxygen consumption, and carbohydrate metabolism. Surgery 47: 293–300, 1960
Pirolo JS, Liptay MJ, Brunt EM, Shuman TA, Cox JL, Ferguson Jr. TB: Early cardiac allograft rejection is independent of regional myocardial blood flow. Ann Thorac Surg 55: 441–449, 1993
Hamano K, Ohmi M, Esato K, Mohri H: Myocardial tissue blood flow in allotransplanted rat heart with a special reference to acute rejection. J Heart Transplant 8: 48–52, 1989
Bando K, Fraser CD, Chacko VP, Pillai R, Jacobus WE, Cameron DE, Hutchins GM, Reitz BA, Baumgartner WA: Coronary blood flow does not decrease during allograft rejection in heterotopic heart transplants. J Heart Lung Transplant 10: 251–257, 1991
Tilney NL: The extent of immunological injury to the vasculature of cardiac allografts in the rat. Transplantation 17: 561–567, 1974
Galiñanes M, Hearse DJ: Metabolic, functional, and histologic characterization of the heterotopically transplanted rat heart when used as a model for the study of long-term recovery from global ischemia. J Heart Lung Transplant 10: 79–91, 1991
Korecky B, Ganguly PK, Elimban V, Dhalla NS: Muscle mechanics and Ca2+ transport in atrophic heart transplants in rat. Am J Physiol 251: H941-H950, 1986
Klein I, Hong C: Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 77: 1694–1698, 1986
Klein I, Hong C, Schreiber SS: Cardiac atrophy in the heterotopically transplanted rat heart: in vitro protein synthesis. J Mol Cell Cardiol 22: 461–468, 1990
Galiñanes M, Zhai X, Hearse DJ: The effect of load on atrophy, myosin isoform shifts and contractile function: Studies in a novel rat heart transplant preparation. J Mol Cell Cardiol 27: 407–417, 1995
Klein I, Samarel AM, Welikson R, Hong C: Heterotopic cardiac transplantation decreases the capacity for rat myocardial protein synthesis. Circ Res 68: 1100–1107, 1991
Klein I, Hong C, Zerbe TR: Myosin content and myosin isoenzyme distribution in the heterotopic rat heart allograft. J Mol Cell Cardiol 19: 917–921, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Dobbenburgh, J.O., Kasbergen, C., Slootweg, P.J. et al. Heterotopic heart transplantation alters high-energy phosphate metabolism irrespective of cardiac allograft rejection. Mol Cell Biochem 163, 247–252 (1996). https://doi.org/10.1007/BF00408665
Issue Date:
DOI: https://doi.org/10.1007/BF00408665